In its treatment rooms and through athome services, Vital Care provides physician-prescribed infusion therapies to patients with a range of needs, be it nutrition support or treatment of a chronic disease. While franchises such as DripBar and Liquivida Lounge offer IV drips with names such as “Soother” and “Time Machine,” aimed at those looking for an aesthetic result or perhaps a hangover cure, Vital Care operates firmly in the medical segment as a pharmaceutical franchise. Franchisees typically fall into one of three buckets: pharmacists, healthcare executives and experienced business owners. Healthcare-focused private equity firm Linden Capital Partners acquired Vital Care from its founder, Johnny Bell, in October 2020. Last year, Berkshire Partners and Leonard Green & Partners made a strategic investment in the company. Linden Capital remains an ongoing investor alongside management and the Bell family. Vital Care is new on this ranking. Its systemwide sales increased from $350 million in 2021 to $868 million in 2023, up nearly 148 percent. Unit growth was 43.4 percent during the three-year period as Vital Care ended 2023 with 76 locations.
| F&S Rank 2024 | Prior Year Rank | 2021-2023 Sales Growth % | 2021-2023 Unit Growth % |
|---|---|---|---|
| 14 | 77 | 147.90% | 43.40% |